OTC Markets OTCPK - Delayed Quote USD

(MNIVF)

Compare
0.7400
0.0000
(0.00%)
At close: January 27 at 3:00:00 PM EST
Loading Chart for MNIVF
DELL
  • Previous Close 0.0000
  • Open --
  • Bid 0.0001 x --
  • Ask 1,000.7500 x --
  • Day's Range --
  • 52 Week Range 0.7400 - 0.7400
  • Volume --
  • Avg. Volume 4,375
  • Market Cap (intraday) 291.729M
  • Beta (5Y Monthly) 1.41
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0100
  • Earnings Date Feb 20, 2025 - Feb 24, 2025
  • Forward Dividend & Yield 0.03 (4.55%)
  • Ex-Dividend Date Sep 5, 2024
  • 1y Target Est --

Monash IVF Group Limited provides assisted reproductive and specialist women imaging services in Australia and Malaysia. The company offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services. Monash IVF Group Limited was incorporated in 2014 and is based in Cremorne, Australia.

www.monashivfgroup.com.au

997

Full Time Employees

June 30

Fiscal Year Ends

Recent News: MNIVF

View More

Performance Overview: MNIVF

Trailing total returns as of 1/28/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

MNIVF
0.00%
S&P/ASX 200 [XJO]
3.36%

1-Year Return

MNIVF
0.00%
S&P/ASX 200 [XJO]
11.62%

3-Year Return

MNIVF
0.00%
S&P/ASX 200 [XJO]
20.68%

5-Year Return

MNIVF
0.00%
S&P/ASX 200 [XJO]
20.07%

Compare To: MNIVF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MNIVF

View More

Valuation Measures

Annual
As of 1/27/2025
  • Market Cap

    291.73M

  • Enterprise Value

    369.77M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.80

  • Price/Book (mrq)

    1.89

  • Enterprise Value/Revenue

    2.31

  • Enterprise Value/EBITDA

    54.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -2.56%

  • Return on Assets (ttm)

    -0.62%

  • Return on Equity (ttm)

    -2.28%

  • Revenue (ttm)

    255.22M

  • Net Income Avi to Common (ttm)

    -6.53M

  • Diluted EPS (ttm)

    -0.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    11.33M

  • Total Debt/Equity (mrq)

    54.88%

  • Levered Free Cash Flow (ttm)

    39.54M

Research Analysis: MNIVF

View More

Company Insights: MNIVF

Research Reports: MNIVF

View More